Your browser doesn't support javascript.
loading
Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study.
Dimopoulos, Meletios A; Moreau, Philippe; Palumbo, Antonio; Joshua, Douglas; Pour, Ludek; Hájek, Roman; Facon, Thierry; Ludwig, Heinz; Oriol, Albert; Goldschmidt, Hartmut; Rosiñol, Laura; Straub, Jan; Suvorov, Aleksandr; Araujo, Carla; Rimashevskaya, Elena; Pika, Tomas; Gaidano, Gianluca; Weisel, Katja; Goranova-Marinova, Vesselina; Schwarer, Anthony; Minuk, Leonard; Masszi, Tamás; Karamanesht, Ievgenii; Offidani, Massimo; Hungria, Vania; Spencer, Andrew; Orlowski, Robert Z; Gillenwater, Heidi H; Mohamed, Nehal; Feng, Shibao; Chng, Wee-Joo.
Afiliación
  • Dimopoulos MA; School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. Electronic address: mdimop@med.uoa.gr.
  • Moreau P; University of Nantes, Nantes, France.
  • Palumbo A; University of Turin, Turin, Italy.
  • Joshua D; Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
  • Pour L; University Hospital Brno, Brno, Czech Republic.
  • Hájek R; University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Facon T; CHRU Lille Hôpital Claude Huriez, Lille, France.
  • Ludwig H; Wilhelminen Cancer Research Institute, Wilhelminenspital, Vienna, Austria.
  • Oriol A; Institut Català d'Oncologia, Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain.
  • Goldschmidt H; Heidelberg Medical University, Heidelberg, Germany.
  • Rosiñol L; Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain.
  • Straub J; Vseobecna fakultni nemocnice v Praze, Prague, Czech Republic.
  • Suvorov A; Hematological Department, First Republican Clinical Hospital of Udmurtia, Izhevsk, Russia.
  • Araujo C; Centre Hospitalier de la Cote Basque, Bayonne, France.
  • Rimashevskaya E; Semashko Central Clinical Hospital, Moscow, Russia.
  • Pika T; Department of Hematooncology, University Hospital Olomouc, Olomouc, Czech Republic.
  • Gaidano G; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
  • Weisel K; Universitatsklinikum Tubingen, Tubingen, Germany.
  • Goranova-Marinova V; University Multiprofile Hospital for Active Treatment Sveti Georgi and Hematology Clinic, Plovdiv, Bulgaria.
  • Schwarer A; Box Hill Hospital, Box Hill, Victoria, Australia.
  • Minuk L; London Health Sciences Centre, Western University, London, Ontario, Canada.
  • Masszi T; Department of Haematology and Stem-cell Transplant, St Istvan and St Laszlo Hospital of Budapest, Budapest, Hungary.
  • Karamanesht I; Kyiv Center for Bone Marrow Transplantation, Kyiv, Ukraine.
  • Offidani M; Clinica di Ematologia, Azienda Ospedaliero Universitaria Ospedali Riuniti Umberto I-G.M. Lancisi-G. Salesi di Ancona, Ancona, Italy.
  • Hungria V; Irmandade da Santa Casa de Misericórdia de Sao Paulo, Sao Paulo, Brazil.
  • Spencer A; Alfred Health-Monash University, Melbourne, Victoria, Australia.
  • Orlowski RZ; The University of Texas MD Anderson Cancer Center, The University of Texas, Houston, TX, USA.
  • Gillenwater HH; Onyx Pharmaceuticals, Inc., an Amgen subsidiary, South San Francisco, CA, USA.
  • Mohamed N; Onyx Pharmaceuticals, Inc., an Amgen subsidiary, South San Francisco, CA, USA.
  • Feng S; Onyx Pharmaceuticals, Inc., an Amgen subsidiary, South San Francisco, CA, USA.
  • Chng WJ; National University Cancer Institute, National University Health System, Singapore and Cancer Science Institute of Singapore, National University of Singapore, Singapore.
Lancet Oncol ; 17(1): 27-38, 2016 Jan.
Article en En | MEDLINE | ID: mdl-26671818
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiple Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiple Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article